Anatomics

Executive Summary

Anatomics, founded in 1995 and headquartered in Melbourne, Australia, is a commercial-stage medical device company specializing in patient-specific and off-the-shelf surgical implants and planning tools. Leveraging CT-derived 3D modeling and additive manufacturing, the company offers a range of polymer and titanium implants (e.g., StarPore Thoracic, SkullPro beanie, SpineBox) as well as software platforms (AnatomicsRx, AnatomicsC3D) for neurosurgery, plastic/reconstructive, oral-maxillofacial, orthopedic, ENT, and thoracic procedures. With over two decades of experience, Anatomics has established itself as a niche player in the personalized implant space, serving surgeons who require precise, anatomically matched solutions. The company's competitive advantage lies in its ability to combine advanced imaging, proprietary design software, and 3D printing to produce implants that improve surgical outcomes and reduce operating times. As the market for personalized medicine and additive manufacturing in healthcare grows, Anatomics is well-positioned to expand its footprint, particularly in the U.S. and Europe. Key upcoming catalysts include potential FDA clearances for new implant lines, expansion into additional surgical specialties (e.g., spine and trauma), and clinical publications supporting the efficacy of their technology. Given its established commercial presence and innovative product pipeline, Anatomics represents a compelling opportunity in the patient-specific implant space.

Upcoming Catalysts (preview)

• Q1 2027FDA clearance of new 3D-printed titanium spine implant60% success
• Q3 2026Expansion into European markets via CE marking of soft tissue implants70% success
• Q4 2026Publication of clinical study results for SkullPro beanie in cranioplasty80% success